Health

Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders

Leads Biolabs grants Oblenio Bio an exclusive option to license LBL-051, a first-in-class CD19xBCMAxCD3tri-specific T-cell engager antibody OAKLAND, Calif. and NANJING, China, Nov. 7, 2024 /PRNewswire/ -- Aditum Bio and Leads Biolabs today announced the formation of Oblenio Bio, which is being f...

2024-11-07 16:29 1605

Fosun Attends CIIE for the Seventh Time - Guo Guangchang: Confident that China's High-Level Openness is a Historical Opportunity

HONG KONG, Nov. 7, 2024 /PRNewswire/ -- On November 5, the 7th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center inShanghai. As a seven-time attendee of the CIIE, Fosun showcased the latest achievements in innovation and global operations at its Fosun...

2024-11-07 13:18 1832

Approx. USD 4.0 M Invested in Product Development for NTDs - GHIT's First Investment in the Development of Diagnostics for Trachoma

TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximatelyJPY 578 million ( USD 4.0 million1) in four projects for the development of new diagnostics and drugs for neglected tropical diseases (NTDs) and malaria.2  GH...

2024-11-07 10:00 1459

Cyient DLM Wins Long Term Deal with Honeywell Aerospace Technologies to Provide Aircraft Cooling Technology

HYDERABAD, India, Nov. 7, 2024 /PRNewswire/ -- Cyient DLM, an integrated partner for design-led manufacturing, announced its partnership with Honeywell Aerospace Technologies for the ground-breaking micro vapor cycle system (Micro VCS), aimed to revolutionize aircraft cooling technology. Cyient D...

2024-11-07 00:11 1880

BRACCO TRIPLES PRODUCTION OF ITS INNOVATIVE CONTRAST AGENT FOR ULTRASOUND IN GENEVA, INAUGURATING A SECOND FACILITY

The significant investment increases the production of CEUS microbubbles The imaging platform for ultrasound, the fruit of Bracco's research, assists doctorsall over the world with more accurate diagnostic data, improving patients' quality of life and facilitating personalized treatment plans PL...

2024-11-06 22:42 1423

Singapore President Tharman's Calligraphy Auctioned for S$308,888 on DeeDa to Benefit the Underprivileged

SINGAPORE, Nov. 6, 2024 /PRNewswire/ -- On November 2, the Singapore Red Cross Society celebrated its 75th Anniversary Benefit Gala ("the Gala") at Shangri-La Singapore. Among the charity auction items was a piece of calligraphy by Singaporean President Tharman Shanmugaratnam, titledWorking Toget...

2024-11-06 19:43 5608

Dallah Hospital Al Nakheel Achieves Global Healthcare Accreditation, Reinforcing its Commitment to Excellence in Medical Travel

PALM BEACH GARDENS, Fla., Nov. 6, 2024 /PRNewswire/ -- Dallah Hospital Al Nakheel, a leading healthcare institution located in the heart of Riyadh, Saudi Arabia, is proud to announce its accreditation by Global Healthcare Accreditation (GHA) for Medical Travel Services. This prestigious recogniti...

2024-11-06 19:00 1174

Esaote Group expands production in India

Innovative series of ultrasound systems are now "Made in India" at the new manufacturing site of subsidiary Esaote Asia Pacific Diagnostic Private Limited in Uttar Pradesh NOIDA, India, Nov. 6, 2024 /PRNewswire/ -- Esaote Group, a leading Italian innovator in medical imaging - ultrasound, dedica...

2024-11-06 18:30 1491

CROWN AESTHETICS PROVIDES CAVENDISH CLINICS WITH AWARD-WINNING SKINPEN® PRECISION TO UPGRADE ITS MICRONEEDLING DEVICE OFFERING

LONDON, Nov. 6, 2024 /PRNewswire/ -- Crown Aesthetics, a Crown Laboratories company and leading innovator in the dermatologic and aesthetics industry, is proud to announce that Cavendish Clinics, one of theUnited Kingdom's ("UK") premier aesthetic clinic groups, has upgraded their microneedling d...

2024-11-06 17:00 1236

ASH 2024 | Results From Three Clinical Studies of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax Selected for Presentations, Including an Oral Report

ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that the latest results...

2024-11-06 16:09 1401

ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year

ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that multiple studies o...

2024-11-06 15:56 1589

Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma

NANJING, China, Nov. 6, 2024 /PRNewswire/ -- On November 1, Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-034, a humanized bispecific T-cell engaging antibody targeting both GPRC5D and CD3 which is independently developed by Leads Biolabs with glo...

2024-11-06 15:20 1201

Antengene Presents Results from Three Investigational Programs at the 2024 SITC Annual Meeting

SHANGHAI and HONG KONG, Nov. 6, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cance...

2024-11-06 09:08 1392

Antengene to Present Results from Two Late-Stage Studies of Selinexor Signaling Potential Clinical Breakthrough at ASH 2024

SHANGHAI and HONG KONG, Nov. 6, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cance...

2024-11-06 08:30 1428

MedAdvisor Solutions Launches Telehealth Service on MedAdvisor Patient App, Further Enhancing Access to Care

Patients can now book virtual provider consultations within the App MELBOURNE, Australia, Nov. 6, 2024 /PRNewswire/ -- MedAdvisor Solutions, a global leader in pharmacy-driven patient engagement solutions, announced today that new Telehealth functionality is now available within the MedAdvisor ...

2024-11-06 06:47 1396

Inside Infinitus: Innovating Customer Service Excellence in China

GUANGZHOU, China, Nov. 6, 2024 /PRNewswire/ -- "Hello, thank you for calling!" This familiar phrase is often heard when dialing into customer service hotlines. The "heard yet unseen" centers, staffed by professionals adept at listening and addressing customer concerns, form the backbone of the se...

2024-11-06 03:04 1362

FWD Group announces strong new business growth update

HONG KONG, Nov. 5, 2024 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "FWD") today announced strong new business growth highlights for the nine months ended30 September 2024. * Value of new business (VNB) of US$623 million, with underlying[i]  year-on-year growth of 16 per cent, ...

2024-11-05 16:30 1311

The Adecco Group: Q3 2024 RESULTS

Robust performance in challenging markets; volumes stabilising ZURICH, Nov. 5, 2024 /PRNewswire/ -- * Revenues -5% yoy organic TDA, -3% yoy organic, a solid result given market conditions, high comparison base; volumes stabilising * By GBU, Adecco -5%, with good results across Asia, Iberia, E...

2024-11-05 13:45 1176

Ping An Selected on Forbes' "World's Best Employer 2024" List, 2nd among China's Financial Companies

HONG KONG and SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318) climbed 29 spots to 318th on Forbes World's Best Employers 2024 list. It ranked #2 amongChina's financial compa...

2024-11-04 18:16 2126

Embrace Autumn Outdoor Activities: Renowned Traditional Chinese Medicine Expert Professor Tinly Wong Tin-Chee Offers Effective Solutions for Relieving Post-Exercise Muscle Soreness with Massage, Herbal Oils, and Plasters

HONG KONG, Nov. 4, 2024 /PRNewswire/ -- As autumn settles in and temperatures begin to drop, many individuals embrace outdoor activities such as running, cycling, and hiking, delighting in the beauty of nature. However, post-exercise muscle soreness can become a common challenge for those who typ...

2024-11-04 09:00 3016
1 ... 3456789 ... 580